브롤루시주맙: 두 판 사이의 차이

브롤루시주맙 (원본 보기)

크기가 바뀐 것이 없음 , 2022년 2월 15일 (화)

잔글

편집

13,127

번

@@ 6번째 줄: / 6번째 줄: @@
 == 관련 연구 ==
 * [[OSPREY]]<ref>Dugel PU et al. Brolucizumab vs Aflibercept in Participants with wAMD : A Randomized Trial. ''Ophthalmology''. 2017 Sep;124(9):1296-1304. [https://pubmed.ncbi.nlm.nih.gov/28551167/ 연결]</ref>
-* [[HAWK]] and HARRIER<ref>Dugel PU et al; HAWK and HARRIER Study Investigators. HAWK and HARRIER : P3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for wAMD. ''Ophthalmology''. 2020 Jan;127(1):72-84. [https://pubmed.ncbi.nlm.nih.gov/30986442/ 연결]</ref>
+* [[HAWK and HARRIER]]<ref>Dugel PU et al; HAWK and HARRIER Study Investigators. HAWK and HARRIER : P3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for wAMD. ''Ophthalmology''. 2020 Jan;127(1):72-84. [https://pubmed.ncbi.nlm.nih.gov/30986442/ 연결]</ref>
 {{참고}}